LON:EVOK Evoke (EVOK) Share Price, News & Analysis GBX 46.70 -0.65 (-1.37%) As of 11:54 AM Eastern Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesBuy This Stock About Evoke Stock (LON:EVOK) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Evoke alerts:Sign Up Key Stats Today's Range 45.65▼ 47.3550-Day Range 47.35▼ 72.8052-Week Range 36.70▼ 77.80Volume1.28 million shsAverage Volume1.94 million shsMarket Capitalization£210.01 millionP/E RatioN/ADividend YieldN/APrice TargetGBX 106.25Consensus RatingModerate Buy Company Overview evoke plc (and together with its subsidiaries, "evoke" or the "Group") is one of the world's leading betting and gaming companies. The Group owns and operates internationally renowned brands including William Hill, 888, and Mr Green. Incorporated in Gibraltar, and headquartered and listed in London, the Group operates from offices around the world. The Group's vision is to make life more interesting and its mission is to delight players with world-class betting and gaming experiences. Find out more at: https://www.evokeplc.com Read More Evoke Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks37th Percentile Overall ScoreEVOK MarketRank™: Evoke scored higher than 37% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion4.0 / 5Analyst RatingModerate Buy Consensus RatingEvoke has received a consensus rating of Moderate Buy. The company's average rating score is 2.75, and is based on 3 buy ratings, 1 hold rating, and no sell ratings.Upside PotentialEvoke has a consensus price target of GBX 106.25, representing about 127.5% upside from its current price of GBX 46.70.Amount of Analyst CoverageEvoke has only been the subject of 3 research reports in the past 90 days.Read more about Evoke's stock forecast and price target. Earnings and Valuation0.0 / 5Proj. Earnings GrowthN/A Price to Earnings Ratio vs. the MarketThe P/E ratio of Evoke is -186.06, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Evoke is -186.06, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. Short InterestN/AShort Interest LevelN/A Short InterestThere is no current short interest data available for EVOK. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldEvoke does not currently pay a dividend.Dividend GrowthEvoke does not have a long track record of dividend growth. Sustainability and ESGN/AEnvironmental ScoreN/A Short InterestThere is no current short interest data available for EVOK. News and Social Media1.7 / 5News Sentiment0.13 News SentimentEvoke has a news sentiment score of 0.13. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.43 average news sentiment score of Consumer Cyclical companies.News Coverage This WeekMarketBeat has tracked 6 news articles for Evoke this week, compared to 6 articles on an average week.MarketBeat Follows3 people have added Evoke to their MarketBeat watchlist in the last 30 days. Company Ownership0.8 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Evoke insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 9.35% of the stock of Evoke is held by insiders.Percentage Held by Institutions41.77% of the stock of Evoke is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Evoke's insider trading history. Receive EVOK Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Evoke and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. EVOK Stock News HeadlinesJPMorgan Chase & Co. Reaffirms "Neutral" Rating for Evoke (LON:EVOK)October 5 at 2:11 AM | americanbankingnews.comEvoke Advisors Ranked No. 1 on Forbes' 'America's Top RIA Firms' List for Fourth Consecutive YearOctober 3, 2025 | tmcnet.comForget AI Stocks — This Device Will REPLACE the MicrochipWhile everyone's chasing the same AI plays, George Gilder is focused on something completely different. He says a 4-nanometer device that's 80 MILLION times more powerful than the chip he gave Reagan is now being made in America for the first time. And he's identified 3 companies that control this technology.October 8 at 2:00 AM | Banyan Hill Publishing (Ad)Evoke Advisors Ranked No. 1 on Forbes’ ‘America's Top RIA Firms’ List for Fourth Consecutive YearOctober 3, 2025 | finance.yahoo.comComments on autism evoke confusion and hope among autistic people and their familiesSeptember 29, 2025 | msn.comTrump’s comments on autism evoke anger and hope among people with autism and their familiesSeptember 29, 2025 | bostonglobe.comBTrump's comments on autism evoke anger and hope among autistic people and their familiesSeptember 29, 2025 | msn.comEvoke Entertainment Signs Rod Lurie, Director Of ‘The Outpost’ And ‘The Contender’September 17, 2025 | msn.comSee More Headlines EVOK Stock Analysis - Frequently Asked Questions How have EVOK shares performed this year? Evoke's stock was trading at GBX 61.15 on January 1st, 2025. Since then, EVOK stock has decreased by 23.6% and is now trading at GBX 46.70. How were Evoke's earnings last quarter? Evoke plc (LON:EVOK) issued its earnings results on Wednesday, August, 13th. The company reported $1.20 earnings per share (EPS) for the quarter. Evoke had a negative trailing twelve-month return on equity of 517.98% and a negative net margin of 8.50%. How do I buy shares of Evoke? Shares of EVOK stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock. Company Calendar Last Earnings8/13/2025Today10/08/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeLON SectorConsumer Cyclical Industry Gambling Sub-IndustryN/A Current SymbolLON:EVOK CIKN/A Webwww.evokeplc.com Phone350-2004-9800FaxN/AEmployees11,634Year FoundedN/APrice Target and Rating Average Price Target for EvokeGBX 106.25 High Price TargetGBX 140 Low Price TargetGBX 82 Potential Upside/Downside+127.5%Consensus RatingModerate Buy Rating Score (0-4)2.75 Research Coverage4 Analysts Profitability EPS (Trailing Twelve Months)GBX (0.25) Trailing P/E RatioN/A Forward P/E Ratio3.66 P/E GrowthN/ANet Income-£177.72 million Net Margins-8.50% Pretax MarginN/A Return on Equity-517.98% Return on Assets0.88% Debt Debt-to-Equity Ratio-3,162.57 Current Ratio0.58 Quick RatioN/A Sales & Book Value Annual Sales£1.78 billion Price / Sales0.12 Cash FlowN/A Price / Cash FlowN/A Book ValueGBX (12.49) per share Price / Book-3.74Miscellaneous Outstanding Shares449,693,000Free FloatN/AMarket Cap£210.01 million OptionableN/A Beta0.84 Options Trading Made Easy - Download NowLearn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.Get This Free Report This page (LON:EVOK) was last updated on 10/8/2025 by MarketBeat.com Staff From Our PartnersMelt-up warning America’s $37.5 trillion debt spiral, soaring deficits, and repeated credit downgrades are exactly what Porter...Porter & Company | SponsoredURGENT: The Market's 3 Red Flags Are FlashingThe warning signs that preceded the 2008 crash are reappearing: an irrational NASDAQ bubble, a record-high gol...StockEarnings | SponsoredBitcoin grabs headlines, but smart money likes this tokenBitcoin grabs headlines, but smart money likes this token My research team has identified the token positio...Crypto 101 Media | SponsoredBuilding The Infrastructure for the Coming Financial ResetWhile China pushes nearly $1 trillion through its new digital currency, one emerging company is quietly buildi...Intellistake | SponsoredYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredNvidia Times 1,000,000Nvidia’s latest AI chip is a $25,000 powerhouse — with 80 billion transistors and the ability to perform 60 tr...Paradigm Press | SponsoredForget AI Stocks — This Device Will REPLACE the MicrochipWhile everyone's chasing the same AI plays, George Gilder is focused on something completely different. He ...Banyan Hill Publishing | SponsoredTrump's Law S.1582: $21T Dollar Revolution ComingDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Evoke plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Evoke With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.